Scandinavian ChemoTech
Logotype for Scandinavian ChemoTech

Scandinavian ChemoTech (CMOTEC) investor relations material

Scandinavian ChemoTech Q4 2025 earnings summary

Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.
Logotype for Scandinavian ChemoTech
Q4 2025 earnings summary17 Feb, 2026

Executive summary

  • Achieved stronger-than-expected Q4 performance with significant revenue growth and improved cash flow year-over-year.

  • Animal Care segment drove all sales, with treatment kit volumes more than doubling from 2024.

  • Clinical validation of Tumour Specific Electroporation (TSE) technology in veterinary oncology reinforced market positioning.

  • Strategic focus sharpened, with North America as the primary growth market and ongoing clinical progress in India.

Financial highlights

  • Q4 net sales: 2,648 KSEK (up from 2,041 KSEK in Q4 2024); full-year net sales: 12,285 KSEK (up from 6,566 KSEK in 2024).

  • Q4 net loss: -2,524 KSEK (improved from -3,167 KSEK); full-year net loss: -8,056 KSEK (improved from -13,717 KSEK).

  • Q4 cash flow from operations: -338 KSEK (improved from -2,172 KSEK); full-year: -3,744 KSEK (improved from -13,145 KSEK).

  • Cash and cash equivalents at year-end: 3,668 KSEK (up from 949 KSEK).

  • Equity/assets ratio at year-end: 24% (down from 45%).

Outlook and guidance

  • Management expects continued growth, with North America as the cornerstone of the strategy.

  • Ongoing R&D and next-generation vetIQure platform development planned, with initial tests targeted for 2026.

  • Additional funding required to maintain operations over the next twelve months; management actively seeking financing.

Impact of consultant model on operational costs?
TSE study validation: Impact on market strategy?
Detail plans for securing additional funding.
Partial view of Summaries dataset, powered by Quartr API
Research faster. Power your platform.

Next Scandinavian ChemoTech earnings date

Logotype for Scandinavian ChemoTech
Q1 202628 Apr, 2026
Scandinavian ChemoTech
Your earnings 
season toolkit.
Download
Free on both iOS & Android.

Next Scandinavian ChemoTech earnings date

Logotype for Scandinavian ChemoTech
Q1 202628 Apr, 2026

The essential earnings season companion

The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.

Live calls and transcripts

Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.

Find what you need faster

Search for any keyword across all transcripts simultaneously.

Easily store key findings

Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.

Your watchlist. Your dashboard.

Follow the companies that matter to you. Get a personalized feed with real-time updates.

Be the first to know

Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.

Consensus estimates

Access analyst consensus estimates, valuation multiples, and revenue segments splits.

All IR material in one place

The easiest way to stay updated during earnings season.

Global coverage

All events from public companies. Live and recorded.

Just click and listen

No webcast links. No manual registrations.

Research anytime, anywhere

Built for professionals. Loved by everyone. Try our free mobile app.

excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
App-store-avatar.png play-store-avatar.png
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
play-store-avatar
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
App-store-avatar.png play-store-avatar.png
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
App-store-avatar.png play-store-avatar.png
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
play-store-avatar
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
App-store-avatar.png play-store-avatar.png
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
x-avatar
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
App-store-avatar.png play-store-avatar.png
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
x-avatar
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
x-avatar
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
App-store-avatar.png play-store-avatar.png
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
x-avatar
@theshortbearx.com

Frequently asked questions

Scandinavian ChemoTech is a medical technology company specializing in innovative treatment solutions for cancer and chronic pain. The company develops and markets therapies based on its patented Tumor-Specific Electroporation (TSE) technology, designed to enhance the effectiveness of chemotherapy for specific cancers. Its products are intended to provide minimally invasive and targeted treatments.

Quartr provides global coverage of all investor relation material from public companies.

  • Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.

  • Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.

  • Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.

Yes, the Quartr mobile app is free on both iOS and Android.

Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.

Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.

Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.

Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.

Explore our global coverage